Annual EBIT
-$176.49 M
+$161.99 M+47.86%
31 December 2023
Summary:
Beam Therapeutics annual earnings before interest & taxes is currently -$176.49 million, with the most recent change of +$161.99 million (+47.86%) on 31 December 2023. During the last 3 years, it has risen by +$215.98 million (+55.03%). BEAM annual EBIT is now -134.83% below its all-time high of -$71.65 million.BEAM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$106.50 M
-$1.61 M-1.53%
30 September 2024
Summary:
Beam Therapeutics quarterly earnings before interest & taxes is currently -$106.50 million, with the most recent change of -$1.61 million (-1.53%) on 30 September 2024. Over the past year, it has dropped by -$239.36 million (-180.16%). BEAM quarterly EBIT is now -180.16% below its all-time high of $132.86 million, reached on 31 December 2023.BEAM Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$182.67 M
+$1.76 M+0.96%
30 September 2024
Summary:
Beam Therapeutics TTM earnings before interest & taxes is currently -$182.67 million, with the most recent change of +$1.76 million (+0.96%) on 30 September 2024. Over the past year, it has dropped by -$6.19 million (-3.51%). BEAM TTM EBIT is now -153.52% below its all-time high of -$72.05 million, reached on 30 September 2018.BEAM TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BEAM EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -180.2% | -3.5% |
| 3 y3 years | +55.0% | -67.8% | +53.5% |
| 5 y5 years | -134.8% | -303.9% | -143.1% |
BEAM EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +55.0% | -180.2% | +1.6% | -3.5% | +54.1% |
| 5 y | 5 years | -134.8% | +55.0% | -180.2% | +46.9% | -143.1% | +54.1% |
| alltime | all time | -134.8% | +55.0% | -180.2% | +46.9% | -153.5% | +54.1% |
Beam Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$106.50 M(+1.5%) | -$182.67 M(-1.0%) |
| June 2024 | - | -$104.89 M(+0.7%) | -$184.44 M(+1.5%) |
| Mar 2024 | - | -$104.13 M(-178.4%) | -$181.69 M(+2.9%) |
| Dec 2023 | -$176.49 M(-47.9%) | $132.86 M(-222.7%) | -$176.49 M(-55.7%) |
| Sept 2023 | - | -$108.27 M(+6.0%) | -$398.33 M(+4.4%) |
| June 2023 | - | -$102.15 M(+3.3%) | -$381.36 M(+5.6%) |
| Mar 2023 | - | -$98.93 M(+11.2%) | -$361.18 M(+6.7%) |
| Dec 2022 | -$338.48 M(-13.8%) | -$88.98 M(-2.5%) | -$338.48 M(+8.1%) |
| Sept 2022 | - | -$91.30 M(+11.4%) | -$312.98 M(+7.4%) |
| June 2022 | - | -$81.97 M(+7.5%) | -$291.31 M(+8.6%) |
| Mar 2022 | - | -$76.22 M(+20.1%) | -$268.32 M(-31.6%) |
| Dec 2021 | -$392.46 M | -$63.48 M(-8.8%) | -$392.46 M(+6.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | -$69.63 M(+18.1%) | -$369.78 M(+9.6%) |
| June 2021 | - | -$58.97 M(-70.6%) | -$337.47 M(+10.7%) |
| Mar 2021 | - | -$200.37 M(+391.1%) | -$304.78 M(+129.6%) |
| Dec 2020 | -$132.76 M(+76.7%) | -$40.80 M(+9.3%) | -$132.76 M(+12.2%) |
| Sept 2020 | - | -$37.32 M(+42.0%) | -$118.33 M(+19.5%) |
| June 2020 | - | -$26.29 M(-7.3%) | -$99.03 M(+9.6%) |
| Mar 2020 | - | -$28.36 M(+7.5%) | -$90.40 M(+20.3%) |
| Dec 2019 | -$75.15 M(-35.6%) | -$26.37 M(+46.3%) | -$75.15 M(+1.6%) |
| Sept 2019 | - | -$18.02 M(+2.1%) | -$73.98 M(-42.2%) |
| June 2019 | - | -$17.65 M(+34.7%) | -$128.01 M(+16.0%) |
| Mar 2019 | - | -$13.11 M(-48.0%) | -$110.36 M(+13.5%) |
| Dec 2018 | -$116.74 M | -$25.19 M(-65.0%) | -$97.25 M(+35.0%) |
| Sept 2018 | - | -$72.05 M | -$72.05 M |
FAQ
- What is Beam Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Beam Therapeutics?
- What is Beam Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Beam Therapeutics?
- What is Beam Therapeutics quarterly EBIT year-on-year change?
- What is Beam Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Beam Therapeutics?
- What is Beam Therapeutics TTM EBIT year-on-year change?
What is Beam Therapeutics annual earnings before interest & taxes?
The current annual EBIT of BEAM is -$176.49 M
What is the all time high annual EBIT for Beam Therapeutics?
Beam Therapeutics all-time high annual earnings before interest & taxes is -$71.65 M
What is Beam Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of BEAM is -$106.50 M
What is the all time high quarterly EBIT for Beam Therapeutics?
Beam Therapeutics all-time high quarterly earnings before interest & taxes is $132.86 M
What is Beam Therapeutics quarterly EBIT year-on-year change?
Over the past year, BEAM quarterly earnings before interest & taxes has changed by -$239.36 M (-180.16%)
What is Beam Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of BEAM is -$182.67 M
What is the all time high TTM EBIT for Beam Therapeutics?
Beam Therapeutics all-time high TTM earnings before interest & taxes is -$72.05 M
What is Beam Therapeutics TTM EBIT year-on-year change?
Over the past year, BEAM TTM earnings before interest & taxes has changed by -$6.19 M (-3.51%)